The combination of plasma exchange (PE) and plasma perfusion (PP) in patients with liver disease enables the efficient removal of a significant quantity of toxic substances, as well as the improvement of clotting factors and albumin levels (21). The gene discussed is ALB; the disease is liver disorder.